Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Effect of Virtual Reality Galsses Used on Anxiety and Threatment Compliance in Cancer Patients Receiving Outpatient Chemotherapy

NCT06474780 is registered in ClinicalTrials.gov with Gozde Oz as lead sponsor.

NCT NCT06474780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06474780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Effect of Virtual Reality Galsses Used on Anxiety and Threatment Compliance in Cancer Patients Receiving Outpatient Chemotherapy
Lead sponsor
Gozde Oz
Phase
Observational
Overall status
Unknown status
Start date
June 28, 2024
Completion date
August 25, 2024
Enrollment
900 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer, chemotherapy, treatment compliance, virtual reality